Interim report Q3 2019 is now available

Jon Sigurdsson, President & CEO, comments:

“Sales growth in the third quarter of the year was strong with a good contribution from both prosthetics and bracing & supports while bearing in mind a strong comparable quarter last year. Growth drivers in the quarter include our high-end solutions in both prosthetics and bracing & supports products and recently launched products such as the new PROPRIO FOOT® which we launched in the beginning of the year. With strong sales growth in the first nine months of the year, we are narrowing our full year guidance for organic growth to ~6% compared to the previous guidance of 5-6%.”

Company announcement Q3 2019


Investor Presentation Q3 2019



Webcast

Latest announcements and news

Latest Announcements

Our Interim reports releases, share buyback program and more. Read up on our latest announcements.

Recent News

Recent product announcements, new technologies, investments and more. Read up on our news page.

Other information

Share Information
Össur Annual Report 2018

We are proud to present the 2018 Annual Report detailing the achievements and progress made by Össur in 2018. Striving to minimize our carbon footprint, the Össur Annual Report will not be printed, but only made available electronically on the web and as a pdf.

Upcoming Event

Our Business

Össur is a global leader in non-invasive orthopaedics; innovating, producing, and providing advanced technological solutions within prosthetics and bracing & supports. Learn more about the Össur investment case.

Contact and Email subscription

Contact

Investor Relations Manager

David Hreidarsson
Email:
Mobile: +354 661 8225 | Tel: +354 515 1380

General Inquiries

Email:
Tel: +354 425 3321

Meet the Össur team

We encourage all investment professionals and shareholders to reach out to our IR team should you have any questions.

If you are traveling to Reykjavik in Iceland, Copenhagen in Denmark or Los Angeles in the US and would like to meet with us, please reach out.


Contact IR

Email subscription

To stay up-to-date with our latest investor email alerts, please sign up.